{"name":"Tinea Pharmaceuticals","slug":"tinea-pharmaceuticals","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2025-11-15","type":"pipeline","source":"Medical Dialogues","summary":"After Years of Resistance, NPPA Finally Allows GSK to Discontinue Grisovin FP - Medical Dialogues","headline":"After Years of Resistance, NPPA Finally Allows GSK to Discontinue Grisovin FP","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxNeGpXR1ZvQlk1RldiZlV4SlpjdGJpNWplZDNteEZtNTFJZGZlSmZtODVrbjgydzlac2lrYXJ3SzFfczhrREZfYzVxYkNRS0dhMUdaU1Zhc2pCeE1wSWlMSGJuNFo0ZVV4dlRwa1R2Z01ybGZ6OFlyVW5DYkIwOWNFdXFSc2ZDbTJ0Z3J4SkZnQ01pVkVyaTFiaGtUS2RFSW8?oc=5","date":"2025-09-17","type":"pipeline","source":"ontario.ca","summary":"Ontario Taking Next Steps to Improve Health-Care Access - ontario.ca","headline":"Ontario Taking Next Steps to Improve Health-Care Access","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-gFBVV95cUxPTXVpY1JSOVVUTFlIV2V6c1BIR0t6RDdmLXF4LXVhS3FUY3F5c3lsMWxJNmpRTlp5eTJFNFVYVDJacTdQU2tDaG90aWdTTmZvSkdyUWFhRDFsS210aWctcnhmNHhnd2NQckZrd0gzYnUyUm5QNGhwQVVkQWw3T1F6OTdjME5ZdTZ6OGxZcDU1U2RfeV9FVW4xU3ZsNzA5b3hfLUsyRVhIWWEwcko1UGdWRms2TGlLWXdsc2FhT25yMUEwUE1EQkJyUm1Gd0hKLTFnTHJGOUhDRV9OOXEtRDVEYlZQRGEwRjU4U3J4ZkxZYmlvcFJESVg5dnB30gH_AUFVX3lxTE1WVnZEUW41cEl5ckN1bHBJdm5ZdUNLWTY3WlB2UzRQY1JOZkRHWW44SGpCcVBRdjBKa3hMamFHMHNqZUU5bHVCMGJtcDRKYVRIZ29JSDE2YTFlREZHaXZsZjN4RVJncV93V0RFbGtUVXk3TTFPdUFyWlVZSDRDOTdXY3k5bTBfellkQllMcHZ5anhjMXJ0dkc4ZFk1THdiUElDVnI0dDNWbG1fTFB4TmNIVlQzZUp0NElWNUdNbFktdUxfWWFvZWxuaTdOWExHYTY4NDgzTFVJYy1EeGNJU3loMW51VmtONWRJWjBwbGxnSGs1NFBSUWF2ZnpSQ1Fudw?oc=5","date":"2025-03-28","type":"pipeline","source":"Medical Dialogues","summary":"Drug Safety Alert: IPC Flags Adverse Reactions to Metronidazole, Luliconazole, Dalteparin, Gliclazide,... - Medical Dialogues","headline":"Drug Safety Alert: IPC Flags Adverse Reactions to Metronidazole, Luliconazole, Dalteparin, Gliclazide,...","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE1CRUFMZXNtWTZQLTBOYmZldDlQTV9rZWdCXzRTTlJLOGpXeFM4SFF5aUZqbTNQYTd3SzVuTmlaSWxPQjR0SWw4cVFBNEpZR25oQkgzOFRUZE1LSWM1OFBN?oc=5","date":"2024-12-28","type":"pipeline","source":"nature.com","summary":"Luliconazole-loaded nanostructured lipid carrier: formulation, characterization, and in vitro antifungal evaluation against a panel of resistant fungal strains - nature.com","headline":"Luliconazole-loaded nanostructured lipid carrier: formulation, characterization, and in vitro antifungal evaluation agai","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZEFVX3lxTE1nTjRDOTBHV1BQMkZXUE9JMUJVekRSZGhYWEYwSEpKSWlEM1lLMktoOGVzaWdzTnp4Q1JMZmsxSFFJN19Ra3JIN3BuRHZrdk1RT0pqOUUycmRLaUcyWlVUVnJfWUE?oc=5","date":"2024-11-27","type":"pipeline","source":"Market.us","summary":"Tinea Pedis Treatment Market Size, Share | CAGR Of 5.3% - Market.us","headline":"Tinea Pedis Treatment Market Size, Share | CAGR Of 5.3%","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxPSmRRc29oTUEyUkpKbkhBOE9IclVvbXpnTDBWTjIzaGNoTUJET05DU2E5b3E5bEp4SFNmSW8yMS1LRHJRSlo2ZHVvWUp4X1lPQzcyODRCMFhnVlNzNTBKZXVEOG9kNjRZN2ZJdG1UaDZabWF0emFtbXVaU1F2QndCYURRNUhSRnA1UDFIRA?oc=5","date":"2024-04-24","type":"pipeline","source":"GoodRx","summary":"Prescribing Authority for Pharmacists: Rules and Regulations by State - GoodRx","headline":"Prescribing Authority for Pharmacists: Rules and Regulations by State","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugJBVV95cUxPQU5iWTFVVS1CbFAzS3pTN3ZIb2xfMHNVYnpUT05wZGpwTHZNbWd5a2JQekx5RzNlaS1lb0kyVE9ZNURKQTBvRmRKZTNYbmZreVpmX1BrSktRMzRWRDlJZ3FjN1FCa2tUSmtYcnlmRUNVOU5GS1FTUEt1enAzMFlwWUFVcVhicklSbm9fTFVJRTBZcDhWZm9BRnJGd0dTUnZmVUk0WUEtMEhnYzZtRmFyb04wS21COVZYUzFob3pnYk5uUkN6OHBJZzZidDEwVWZyTVU3TUl3Wk82TEtEWDRMNTRwb2dMQW1XbWxmZmtIMHk0Ym00T0dfN0F2Vk0wQnpsdml0Q3lMQmVXVHlkbVUyYXJnR2Y0WDNEcHpoaDdyMjY3Z0l4VGFVejdGa1FlanpJQlY1WEtNUXlOdw?oc=5","date":"2024-01-31","type":"regulatory","source":"PR Newswire","summary":"Vanda Pharmaceuticals Receives FDA Approval to Proceed with Investigational New Drug VTR-297 a Topical Antifungal Candidate for the Treatment of Onychomycosis - PR Newswire","headline":"Vanda Pharmaceuticals Receives FDA Approval to Proceed with Investigational New Drug VTR-297 a Topical Antifungal Candid","sentiment":"positive"},{"url":"https://news.google.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?oc=5","date":"2022-12-22","type":"pipeline","source":"Medical Dialogues","summary":"Synokem Pharama gets CDSCO panel nod to manufacture, market Naftifine HCL Cream 2% - Medical Dialogues","headline":"Synokem Pharama gets CDSCO panel nod to manufacture, market Naftifine HCL Cream 2%","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2022-11-01","type":"pipeline","source":"Medical Dialogues","summary":"Zydus Naftifine HCL 2% Cream Gets CDSCO Panel nod to treat superficial fungal infection of skin - Medical Dialogues","headline":"Zydus Naftifine HCL 2% Cream Gets CDSCO Panel nod to treat superficial fungal infection of skin","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMickFVX3lxTFB5bjhfamdueGFrd0o1TFViMnpXTjIyYlNyR0p5N1B3bWl5cmFNX29aNnNtUkpmd3RpbVdZTDBtbE9MenJxVEFYai1Xbm9zY2lTdjlwSkRkR0xjcUhZM3RLYzJHcldxSmVNYmM5aWdSNkVRUQ?oc=5","date":"2022-05-27","type":"patent","source":"Pharmacy Times","summary":"Generic Product News: May 2022 - Pharmacy Times","headline":"Generic Product News: May 2022","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxPRWJhdkQxLXhtVVdrTlZlMVJDeGtvN2pOc1JGcnZDeHY1QWNNNkF0M1JscGo0dkZRMWhRTDN0bHN6M1RzbnpBVkhId0tEcldvMjM5QUxydm54WWpYd05wVmVhOVd4RUg1Rzl2eFpibUZubU53QmNpNkg5Rjd0dHliMzBYYnEzQXlPNWg5aVlBM2xHZUpnMjN6RFEzUmtmQjEzMnc?oc=5","date":"2021-11-09","type":"pipeline","source":"The Pharmaceutical Journal","summary":"Recognising common skin conditions in people of colour - The Pharmaceutical Journal","headline":"Recognising common skin conditions in people of colour","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2021-04-08","type":"deal","source":"Medical Dialogues","summary":"ANI Pharma acquires Sandoz NDAs to expand branded products portfolio - Medical Dialogues","headline":"ANI Pharma acquires Sandoz NDAs to expand branded products portfolio","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}